‌

Laigo Bio

Laigo Bio is a SureTACTM precision membrane protein degradation platform founded in 2021 by Neill Moray Mackenzie.

Overview Structured Data Issues Contributors

laigobio.com/en/

Is a

Organization

Company

Company attributes

Industry

CEO

Founder

Neill Moray Mackenzie

Number of Employees (Ranges)

1 – 10

Email Address

contactus@laigobio.com

Investors

‌

The Oncode Oncology Bridge Fund

Cancer Research Horizons

Founded Date

2021

Total Funding Amount (USD)

13,500,000

Latest Funding Round Date

December 4, 2025

Latest Funding Type

Seed

Country

Netherlands

Headquarters

Utrecht

Other attributes

Latest Funding Round Amount (USD)

13,500,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Laigo Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API